By vgreene, 9 June, 2021 Study considerations trial stopped w 75 pts recruited f u duration relative short 30 days
By vgreene, 9 June, 2021 KEY FINDINGS colchicine did not significantly reduce death or hospitalization among community treated pts but had possible benefit in subgroup of PCR positive pts
By vgreene, 9 June, 2021 Colchicine for Community treated Patients With COVID 19 COLCORONA A Phase 3 Randomised Double blinded Adaptive Placebo controlled Multicentre Trial
By vgreene, 9 June, 2021 KEY FINDINGS colchicine did not significantly reduce death or hospitalization among community treated pts but had possible benefit in subgroup of PCR positive pts
By vgreene, 9 June, 2021 Colchicine for Community treated Patients With COVID 19 COLCORONA A Phase 3 Randomised Double blinded Adaptive Placebo controlled Multicentre trial
By vgreene, 9 June, 2021 Awaiting initial tx for neurologic Lyme facial palsy neuritis meningitis encephalitis
